Czech J. Food Sci., 2004, 22(2):73-79 | DOI: 10.17221/3409-CJFS

bovine colostrum - the promising nutraceutical

B. Alexieva, Tz. Markova, E. Nikolova
1 Department of Experimental Cytology, Institute of Experimental Morphology and Anthropology, Bulgarian Academy of Sciences, Sofia, Bulgaria
2 Department of Pharmacology, University of Medicine, Sofia, Bulgaria

Colostrum is the first milk produced after birth and is particularly rich in immunoglobulins, antimicrobial peptides, and growth factors. It is important for the nutrition, growth, and development of newborn infants and contributes to the immunologic defence of neonates. Recent studies suggest that bovine colostrum or some of its constituents may be useful for the prevention and, to some extent, for the treatment of various infectious diseases. A variety of colostral based preparations have been used as feed supplements or colostrum substitutes for neonate calves and pigs. Numerous recent studies suggest that oral administration of bovine colostrum preparations may contribute to human health care both as part of health promoting diet and as an alternative or a supplement to the medical treatment of specified human diseases.

Keywords: diet supplement; nutrient; colostral immunoglobulins; growth factors; human health

Published: April 30, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Alexieva B, Markova T, Nikolova E. bovine colostrum - the promising nutraceutical. Czech J. Food Sci. 2004;22(2):73-79. doi: 10.17221/3409-CJFS.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. A J., S M.S., V G D. (2001): The effects of bovine colostrum supplementation on body composition and exercise performance in active men and women. Nutrition, 17: 243-247. Go to original source... Go to PubMed...
    2. B J.H., O F., P A. (1975): Bactericidal and haemolytic activity of complement in bovine colostrum and serum: effect of proteolytic enzymes and ethylene glycol tetraacetic acid (EGTA). Ann. Immunol. (Paris), Sect. C, 126: 439-451.
    3. B E. P. (2000): Biological activities of bovine glycomacropeptide. Br. J. Nutr., 84, Suppl. 1: 39-46. Go to original source... Go to PubMed...
    4. D W.H., R P. (1989): Insulin-like growth factor I & II. Peptide messenger RNA-like structures, serum and tissue concentrations. Endocrin. Rev., 10: 68-91. Go to original source... Go to PubMed...
    5. D G.P., D E., N H., M A.G., W P.B.D., F K., M C P.I., M D.J. (1989): Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet, 334: 709-712. Go to original source... Go to PubMed...
    6. E W.P., H K.M., O D.P. (1981): Total complement hemolytic activity of colostral whey and sera from dairy cows. Cornell Vet., 71: 54-58. Go to PubMed...
    7. F D.J., T C.O., D A., M D.R., N J., C J.H. (1998): Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J. Infect. Dis., 177: 662-667. Go to original source... Go to PubMed...
    8. G P.K., G H.S. (2000): Oligosaccharides and glycoconjugates in bovine milk and colostrum. Br. J. Nutr., 84, Suppl. 1: 69-74. Go to original source... Go to PubMed...
    9. G P.D., C J.P. (1996): Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J. Acquir. Immune Defic. Syndr., 13: 348-354. Go to original source... Go to PubMed...
    10. H K., K S., Y H., K R., I H. (2000): Detection of cytokines in bovine colostrum. Vet. Immunol. Immunopathol., 76: 183-190. Go to original source... Go to PubMed...
    11. H E., S A., T T., S K., S B., Y T., K T. (1999): Characteristic transfer of colostral components into cerebrospinal fluid via serum in neonatal pigs. Biol. Neonate, 76: 33-43. Go to original source... Go to PubMed...
    12. H M., I R., F K. et al. (1994): Epidermal growth factor enhances repair of rat intestinal mucosa damaged a er oral administration of methotrexate. J. Gastroenterol., 30: 169-176. Go to original source... Go to PubMed...
    13. H K.L., Y R.S. (2000): Improved recovery of insulin-like growth factors (IGFs) from bovine colostrum using alkaline diafiltration. Biotechnol. Appl. Biochem., 32: 161-166. Go to original source... Go to PubMed...
    14. H H.I., R S., B D.H. et al. (1999): Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, shiga toxin producing E. coli, and E. coli expressing intimin and hemolysin. J. Pediatr. Gastroenterol. Nutr., 29: 452-456. Go to original source... Go to PubMed...
    15. K H., S E.L., A -L H., S S., K S., H J., K T.U. (1995): Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J. Appl. Bacteriol., 78: 655-662. Go to original source... Go to PubMed...
    16. K H., M P., G H.S. (2000a): Milk immunoglobulins and complement factors. Br. J. Nutr., 84, Suppl. 1: 75-80. Go to original source... Go to PubMed...
    17. K H., M P., G H.S. (2000b): Bovine milk antibodies for health. Br. J. Nutr., 84, Suppl. 1: 135-146. Go to original source... Go to PubMed...
    18. L D., O A. (1999): Bovine immunoglobulin G, β-lactoglobulin, α-lactalbumin and serum albumin in colostrum and milk during the early post partum period. J. Dairy Sci., 66: 421-430. Go to original source... Go to PubMed...
    19. L E.M., M P. (2001): The role of colostral antibodies in prevention of microbial infections. Curr. Opin. Infect. Dis., 14: 295-300. Go to original source... Go to PubMed...
    20. L V., C A., O J. et al. (1998): Concentrated bovine colostral whey proteins from Streptococcus mutans/Streptococcus sorbinus immunised cows inhibit the adherence of Streptococcus mutans and promote the aggregation of mutans streptococci. J. Dairy Res., 65: 599-607. Go to original source... Go to PubMed...
    21. L V., L M., S E. et al. (1999): Effects of bovine immune and nonimmune whey preparations on the composition and pH response of human dental plaque. Eur. J. Oral Sci., 107: 244-250. Go to original source... Go to PubMed...
    22. M F T.B., B T.E., B G.M. (1997): Regulation of immunoglobulin transfer into mammary secretion of ruminants. In: W D.J.W., B S.R., D S.R., P A.I., P C.G. (eds): Milk Composition Production and Biotechnology. CAB Int., Wallingford, UK: 133-152.
    23. M A., M H., R J., P R., A J., T T. (1997): Effects of bovine colostrum supplementation on serum IGF-1, IgG, hormone and saliva IgA during training. J. Appl. Physiol., 83: 1144-1151. Go to original source... Go to PubMed...
    24. M A.K., M D., U L., E R., T S. (1995): Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a doubleblind, controlled clinical trial. Acta Pediatr., 84: 996-1001. Go to original source... Go to PubMed...
    25. O P.C., C C.L., C J., V L.M., D E.T., D P H.L. (1998): Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin. Infect. Dis., 26: 1324-1329. Go to original source... Go to PubMed...
    26. O H., U M., L D., D R. A., C A.G. (1998): The effect of epidermal growth factor on bacterial translocation in newborn rabbits. J. Pediatr. Surg., 33: 225-288. Go to original source... Go to PubMed...
    27. O M., R T., M H., M M., L K., S S., K H. (1997): Helicobacter pylori in children with abdominal complaints: Has immune bovine colostrum some influence on gastritis? Alpe Adria Microbiol. J., 6: 49-57.
    28. P R.J. (1995): Leading article: peptides and gastrointestinal mucosal integrity. Gut, 37: 595-597. Go to original source... Go to PubMed...
    29. P R.J., F D.N., M D C.E., C D.P., A R.O., J W., G R.A., M T. (1999): Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut, 44: 653-658. Go to original source... Go to PubMed...
    30. P R.J., M D C.E., J W.S. (2000): Colostrum and milk-derived growth factors for the treatment of gastrointestinal disorders. Am. J. Clin. Nutr., 72: 5-14. Go to original source... Go to PubMed...
    31. P R.J., M D C.E., C D.P., F D.N., R T., J W., W A.C., B O., M T. (2001): Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability. Clin. Sci. (Lond), 100: 627-633. Go to original source...
    32. P A. (1995): Regional variations in composition of human milk. In: J R.G. (ed.): Handbook of Milk Composition. Academic Press Inc., San Diego: 115-221. Go to original source...
    33. R R.M., D R., S J. (1997): Oral delivery of antibodies. Clin. Pharmacokinet., 32: 313-323. Go to original source... Go to PubMed...
    34. R N., M S., B R. et al. (1995): 15N -labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J. Nutr., 125: 1238-1244. Go to original source...
    35. R J. A., A R., A A. (1992): Treatment of diarrhea in human immunodeficiency virus infected patients with immunoglobulins from bovine colostrum. J. Clin. Invest., 70: 588-594. Go to original source... Go to PubMed...
    36. S S.A., C T.H., M D., A N.H., A N.J., B H., F G.J., H L. (1998): Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunised bovine colostrum. Pediatr. Infect. Dis. J., 17: 1149-1154. Go to original source... Go to PubMed...
    37. S E., M D., M H. (2000): Nucleosides and nucleotides: natural bioactive substances in milk and colostrum. Br. J. Nutr., 84, Suppl. 1: S59-68. Go to original source... Go to PubMed...
    38. S J., M M., O S., N L., S C. (2000): Endotoxin inactivation by enterally applied colostrum of different composition. Eur. Surg. Res., 34: 68-72. Go to original source... Go to PubMed...
    39. S S.T., L L., V V A. et al. (1994): Prevention of chemotherapy induced ulcerative mucosiotis by transforming growth factor beta. Cancer Res., 54: 1135-1138.
    40. S J.M., V H A.C. (2000): Occurrence, structure, biochemical properties and technological characteristic of lactoferrin. Br. J. Nutr., 84, Suppl. 1: 11-17. Go to original source... Go to PubMed...
    41. S W., D H., L R. (1990): Antibodies from colostrum in oral immunotherapy. J. Clin. Chem. Clin. Biochemie, 28: 19-23.
    42. S H., I T., S T. (2001): Promoting effect of colostrum on the phagocytic activity of bovine polymorphonuclear leukocytes in vitro. Biol. Neonate, 79: 140-144. Go to original source... Go to PubMed...
    43. S S., S Z. (1996): Basic fibroblast growth factor and PDGF in GI diseases. Baillieres Clin. Gastroenterol., 10: 97-112. Go to original source... Go to PubMed...
    44. T C.O., B S.B., B E., L G., R M.J., E R. (1992): Efficacy of bovine milk immunoglobulin concentrate in preventing illness a er Shigella flexneri challenge. Am. J. Trop. Med. Hyg., 47: 276-283. Go to original source... Go to PubMed...
    45. T S., K H., S S. (1995): Immune colostrum in the treatment of Helicobacter pylori gastritis. In: Abstract book of 24th Int. Dairy Congr., 18-22 Sept, Melbourne, Australia.
    46. V B., A U S., J M., P R. (1996): Viable AC-2, a new adult bovine serumand colostrum-based supplement for the culture of mammalian cells. Biotechniques, 20: 702-707. Go to original source... Go to PubMed...
    47. W M., F A., B E.F. et al. (1999): Bovine immunoglobulin concentrate Clostridium difficile retains C. difficile toxin neutralising activity a er passage through the human stomach and small intestine. Gut, 44: 212-217. Go to original source... Go to PubMed...
    48. Z L., C R.A., M T.R., W K.J. (2000): Preventing infectious diseases with passive immunization. Microb. Infect., 2: 701-708. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content